Related references
Note: Only part of the references are listed.Palivizumab use in subjects with congenital heart disease
Stuart A. Cohen et al.
PEDIATRIC CARDIOLOGY (2008)
Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
E Terletskaia-Ladwig et al.
BMC INFECTIOUS DISEASES (2005)
The Pediatric Investigators Collaborative Network on Infections in Canada Study of Predictors of Hospitalization for Respiratory Syncytial Virus Infection for Infants Born at 33 through 35 completed weeks of gestation
BJ Law et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain
J Figueras-Aloy et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Substantial variability in community respiratory syncytial virus season timing
JA Mullins et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
TF Feltes et al.
JOURNAL OF PEDIATRICS (2003)
Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
C Pedraz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: Results from the Palivizumab Outcomes Registry
C Parnes et al.
PEDIATRIC PULMONOLOGY (2003)
Risk factors for bronchiolitis-associated deaths among infants in the United States
RC Holman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage
JR Romero
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease
EAF Simoes
JOURNAL OF PEDIATRICS (2003)
Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
S Leader et al.
JOURNAL OF PEDIATRICS (2003)
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997
DK Shay et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
TG Boyce et al.
JOURNAL OF PEDIATRICS (2000)
Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season
M Sorrentino et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation:: a prospective study
X Carbonell-Estrany et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Share Paper
